| 000 | 01512 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513070123.0 | ||
| 264 | 0 | _c19931230 | |
| 008 | 199312s 0 0 fre d | ||
| 022 | _a0066-2070 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGendre, J P | |
| 245 | 0 | 0 |
_a[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]. _h[electronic resource] |
| 260 |
_bAnnales de gastroenterologie et d'hepatologie _cOct 1993 |
||
| 300 |
_a251-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAminosalicylic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMesalamine |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMary, J Y | |
| 700 | 1 | _aFlorent, C | |
| 700 | 1 | _aModigliani, R | |
| 700 | 1 | _aColombel, J F | |
| 700 | 1 | _aSoulé, J C | |
| 700 | 1 | _aGalmiche, J P | |
| 700 | 1 | _aLerebours, E | |
| 700 | 1 | _aDescos, L | |
| 700 | 1 | _aViteau, J M | |
| 773 | 0 |
_tAnnales de gastroenterologie et d'hepatologie _gvol. 29 _gno. 5 _gp. 251-6 |
|
| 999 |
_c8249803 _d8249803 |
||